Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Ms. Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Ms. Priyadharshini Veeralakshmanan | Amrita Vishwa Vidyapeetham | India

Ms. Priyadharshini Veeralakshmanan is a dedicated PhD scholar at Amrita Vishwa Vidyapeetham, specializing in Medical Oncology with a focus on Breast Cancer Immunology and the immunosuppressive tumour microenvironment (TME), particularly in Triple-Negative Breast Cancer (TNBC). Her doctoral research involves a Phase 2/3 open-label pilot clinical trial to evaluate neoadjuvant metronomic chemotherapy for modulating the TME and enhancing chemo- and immunotherapy responses, quantifying immunosuppressive cells and tumour-infiltrating lymphocytes from blood and tumour tissue. She holds an M.Sc. in Physician Assistant (Medical Oncology) and a B.Sc. in Physician Assistant (General Medicine), with extensive clinical training in oncology, hematology, surgical oncology, radiation oncology, and palliative care. Priyadharshini has strong expertise in flow cytometry, cell culture, in vitro drug testing, cytotoxicity assays, systematic reviews, meta-analysis, and clinical trial design, using advanced analytical tools such as FlowJo, SPSS, and GraphPad Prism. She has authored several publications, with an h-index of 3, over 7 documents, and more than 50 citations. A member of ESMO, ASCO, and I-OSI, she is committed to advancing cancer research, translating innovative findings into clinical practice to improve patient outcomes globally.

Profiles: Orcid | Linked In

Featured publications

Veeralakshmanan, P., Jose, W. M., Udayakumaran, S., Bindhu, M. R., Dutta, D., Rajesh, K., Kavalagunta, S., Bhaskaran, R., Haridas, N. K., Rakesh, M. P., et al. (2025). Multimodal management and outcome of pediatric and adolescent malignant central nervous system tumors: A single‐center retrospective study. Malignancy Spectrum.

Surendran, H. P., Sah, S. K., Veeralakshmanan, P., Nair, P., Ashok, H. P., Unnikrishnan, M. K., Kalavagunta, S., Sasidharan, A., Chandran, D., Poornachary, N. M., et al. (2025). Efficacy of hippocampal avoidance whole brain radiotherapy to preserve the cognitive functions among brain metastasis patients: Systematic review and meta-analysis. Neurology India, 73(5), 715–725.

Irene Litvan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Irene Litvan | Clinical Neuroscience | Best Researcher Award

Dr. Irene Litvan | University of California San Diego | United States

Dr. Irene Litvan, MD, is the Tasch Endowed Professor of Neurology and Director of the Parkinson and Other Movement Disorders Center at the University of California, San Diego. She is internationally recognized for her pioneering work in movement disorders, particularly Parkinson’s disease and related neurodegenerative conditions. As a leading clinician-scientist, she has directed major multicenter and international initiatives to develop clinical and neuropathologic diagnostic criteria, identify disease biomarkers, and advance therapeutic interventions. Her extensive research spans epidemiologic, genetic, and clinico-pathologic correlation studies that have significantly deepened the understanding of movement disorders. Dr. Litvan’s scholarly impact is reflected in 6 published documents, 10 citations, and an h-index of 1. Throughout her distinguished career, she has received consistent funding support from national and international agencies, industry collaborations, and philanthropic organizations. Beyond her research, she has served as a dedicated mentor, shaping the next generation of neurologists and neuroscientists. Dr. Litvan also leads the UC San Diego Parkinson and Other Movement Disorders Center, fostering clinical excellence and research innovation aimed at improving diagnosis, management, and quality of life for individuals with Parkinson’s disease and other movement-related neurological disorders.

Featured Publications

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., et al. (2015). MDS clinical diagnostic criteria for Parkinson’s disease. Movement Disorders, 30(12), 1591–1601.

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology, 65(12), 1863–1872.

Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55(11), 1621–1626.

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., et al. (2007). Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders, 22(12), 1689–1707.

Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., et al. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27(3), 349–356.

Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS–SPSP international workshop. Neurology, 47(1), 1–9.

Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., et al. (2017). Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria. Movement Disorders, 32(6), 853–864.

Rezvan Ghafarzadegan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mrs. Rezvan Ghafarzadegan | Clinical Neuroscience | Best Researcher Award

Mrs. Rezvan Ghafarzadegan | Tarbiat Modares University | Iran

Rezvan Ghafarzadegan is a distinguished nursing scholar specializing in Medical-Surgical Education, holding an M.Sc. in Nursing from Tehran University of Medical Sciences and a B.Sc. in Nursing from Arak University of Medical Sciences, both completed with exceptional academic honors and outstanding GPAs. She is currently a Ph.D. candidate in Nursing at Tarbiat Modares University, demonstrating a strong commitment to advancing nursing education and clinical practice. Rezvan has extensive teaching experience, serving as an instructor for Medical-Surgical Nursing, Emergency Medicine, Internal Diseases, Medical Ethics, Pathophysiology, Orthopedic Surgical Technology, and Introduction to Surgical Technology. She also has broad clinical instruction expertise in Emergency, Internal Medicine (Gastroenterology & Endocrinology), Orthopedics, Neurosurgery, and General Surgery, along with operating room education. Her scholarly contributions include 9 published documents that have collectively earned 31 citations, reflecting her growing impact in the field, and she holds an h-index of 3. Recognized throughout her academic journey as an exceptional talent student, Rezvan combines clinical expertise with a deep dedication to research, striving to improve nursing education and patient care through both her teaching and scientific endeavors.

Profiles: Scopus | Orcid | Research gate

Featured Publications

Zarei, M., Norouzi, N., Teymoori, E., & Ghafarzadegan, R. (2025). Covering sterile instrument tables to prevent airborne bacterial contamination and surgical wound infections: A narrative review of operating room nursing practices. Perioperative Care and Operating Room Management, 100495.

Ghafarzadegan, R., Zarei, M., Norouzi, N., Mirbagher Ajorpaz, N., Lotfi, S. M., Rasooli Manesh, S. M., Akbari, H., & Abedi, A. (2025). Efficacy of an Iranian herbal medicine formula for postoperative constipation in trauma patients with hip and lower limb fractures: A triple-blind, placebo-controlled randomized clinical trial. International Journal of Orthopaedic and Trauma Nursing, 101163.

Javaheri, J., Asgari, M., & Ghafarzadegan, R. (2023). The effect of Nigella sativa powder on blood sugar and lipid profiles in type 2 diabetic patients. Jundishapur Journal of Natural Pharmaceutical Products, e135757.

Sang Yun Seok | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Sang Yun Seok | Clinical Neuroscience | Best Researcher Award 

Prof. Sang Yun Seok,  Busan Bumin Hospital, South Korea.

Dr. Sangyun Seok is a highly accomplished spine surgeon and medical academic whose career spans clinical excellence, international training, and impactful research. He completed his medical education and master’s degree at Dong-A University, followed by intensive clinical training and military service. His professional career includes esteemed positions at Asan Medical Center, Eulji Medical Center, and fellowships in the USA, UK, and Japan, culminating in his current role at Busan Bumin Hospital. Dr. Seok’s primary research focus lies in cervical spine surgery and minimally invasive techniques, with numerous publications in top-tier international journals. His clinical expertise, global collaborations, and forward-looking vision continue to influence the field of spinal surgery.

Profile

Orcid

⭐ Strengths for the Award

  • Focused Research Expertise: His specialized focus on cervical spine surgery and minimally invasive spine techniques addresses high-impact areas in clinical orthopedics and neurosurgery, benefiting both patients and the broader medical community.

  • Robust Publication Record: Dr. Seok has published in top-tier journals including Neurospine, Clinical Spine Surgery, Global Spine Journal, and J Neurosurg Spine, contributing to both practical advancements and theoretical insights in spine surgery.

⚠️ Areas for Improvement

  • Grant Acquisition and Leadership Roles: There is limited information on leading major funded research projects or international consortia. Taking lead investigator roles in large-scale studies or securing competitive research grants would significantly bolster his profile.

  • Innovation and Patents: Future work could include intellectual property contributions, such as device development, patents, or clinical guidelines, to complement his strong publication base.

🎓 Early Academic Pursuits

Dr. Sangyun Seok embarked on his medical journey at Dong-A University College of Medicine in Busan, Korea, where he earned his Bachelor’s degree in Medicine between 2006 and 2012. His passion for advancing medical knowledge led him to pursue a Master’s degree in Medicine from the same institution during 2014–2016, laying a solid academic foundation in clinical and surgical sciences. His formative years were marked by diligence, academic excellence, and a clear focus on the musculoskeletal and spinal health domains.

🏥 Professional Endeavors

Following his academic achievements, Dr. Seok underwent rigorous clinical training at Dong-A University Hospital from 2012 to 2017, where he honed his clinical and surgical skills. After serving his nation through the Korean military service from 2017 to 2020, he returned to the healthcare field with renewed dedication. His professional career advanced rapidly with appointments at Asan Medical Center in Seoul, followed by a tenure as Assistant Professor at Eulji Medical Center in Daejeon (2021–2025). Dr. Seok’s career reflects a blend of clinical service, academic leadership, and global medical engagement, including fellowships in the USA, UK, and Japan. As of 2025, he continues his professional journey at Busan Bumin Hospital, further strengthening Korea’s spine surgery community.

🔬 Contributions and Research Focus

Dr. Seok’s research contributions are deeply rooted in the field of spine surgery, with a sharp focus on the cervical spine and minimally invasive surgical techniques. His academic output reflects a commitment to improving surgical outcomes and patient recovery. Among his impactful works are studies on vertebral osteotomy for cervical myelopathy, postoperative delirium after knee arthroplasty, and minimally invasive approaches in complex cervical procedures. His research has been published in reputable journals such as Neurospine, Clinical Spine Surgery, Global Spine Journal, and Journal of Neurosurgery: Spine, underlining his authority and innovation in spine surgery.

Publication


Title: Analysis of Early Post-Radiation Surgical Management of Metastatic Spinal Tumors
Author: SANGYUN SEOK, Jae Hwan Cho, Hyung Rae Lee, Jae Woo Park, Jin Hoon Park, Dong-Ho Lee, Chang Ju Hwang, Sehan Park
Year: 2025


Title: Mechanical Stability and Clinical Outcomes Following Posterior Cervical Fusion Surgery Using C3-6 Lateral Mass Screw Fixation: En Bloc Versus Regional Screw Fixation
Author: Dong-Ho Lee, SANGYUN SEOK, Woon Sang Lee, Hyung Rae Lee, Sehan Park, Chang Ju Hwang, Jae Hwan Cho
Year: 2025

🏁 Conclusion

Dr. Sangyun Seok is highly deserving of the Best Researcher Award. His trajectory is marked by deep scientific curiosity, technical mastery, and global vision. His work has already contributed meaningfully to advancing spinal surgery, and with continued research leadership, he is poised to make even greater contributions in the years ahead. Recognizing him with this award would not only honor his current accomplishments but also inspire future breakthroughs in spine medicine and academic surgery.

Toru Yoshiura | Clinical Neuroscience | Neuroscience Research Excellence Award

Published on by Neuroscientists

Dr. Toru Yoshiura | Clinical Neuroscience | Neuroscience Research Excellence Award

Dr. Toru Yoshiura,  National Defense Medical College, Japan.

Dr. Toru Yoshiura, a Lieutenant Commander in the Japan Maritime Self-Defense Force (JMSDF) and a board-certified neurosurgeon, has cultivated a remarkable career blending military service, clinical excellence, and academic research. A graduate of the National Defense Medical College, he has pursued specialized training in diving medicine and neuroendoscopic surgery while serving in key clinical and field deployments, including anti-piracy missions. His research focuses on innovative neuroprotective strategies for subarachnoid hemorrhage, and he actively contributes to the education of future neurosurgeons through specialized anatomical dissection courses. Dr. Yoshiura holds multiple national certifications and is an active member of prominent neurosurgical societies, where he plays a leadership role in advancing young professionals.

Profile

Orcid

🎓 Early Academic Pursuits

Born on January 15, 1987, in Hiroshima, Japan, Dr. Toru Yoshiura began his distinguished journey in medicine with a solid academic foundation at the National Defense Medical College, where he pursued his studies from April 2005 to March 2011. During these formative years, he developed a strong inclination toward the intricate world of neurosurgery. His academic journey was not limited to conventional study; he also completed rigorous military medical training at the JMSDF Officer Candidate School in 2011 and the Diving Medical Officer’s Course in 2013. Driven by both curiosity and commitment, Dr. Yoshiura later pursued graduate studies in medicine at the same institution, where he currently investigates novel therapeutic strategies in neurosurgical conditions, particularly focusing on cerebral ischemia models.

⚓ Professional Endeavors

Dr. Yoshiura’s career seamlessly blends clinical excellence with military service. Since 2011, he has been a commissioned officer in the Japan Maritime Self-Defense Force (JMSDF), rising to the rank of Lieutenant Commander. His professional journey commenced with a clinical residency at the National Defense Medical College Hospital, followed by a tenure as a neurosurgeon at JSDF Yokosuka Hospital, where he also took part in the 17th Deployment Surface Force Counter Piracy Enforcement in 2013–2014. Subsequent assignments included advanced clinical residency, service at the JSDF Central Hospital, and another deployment during the 37th Counter Piracy Enforcement (2020–2021). Currently, he practices at the National Defense Medical College Hospital, where he brings both his clinical and research expertise to the forefront.

🧠 Contributions and Research Focus

Dr. Yoshiura has emerged as a dedicated researcher with a keen interest in neuroprotection and neurovascular recovery. His ongoing doctoral research explores the synergistic effects of hydrogen inhalation and intrathecal magnesium sulfate treatment in enhancing ischemic outcomes without suppressing cortical spreading depolarization—work that promises to revolutionize the management of subarachnoid hemorrhage (SAH). Moreover, he serves as the Course Director of the White Matter Dissection Course, a specialized program aimed at enhancing neurosurgical anatomical understanding, further showcasing his commitment to academic mentorship and the future of neurosurgical training.

🏅 Accolades and Recognition

Dr. Yoshiura’s dedication to excellence has been officially recognized through multiple prestigious medical certifications in Japan. He holds certifications from the Japanese Boards of Neurosurgery, Stroke, Neuroendovascular Therapy, and Neurotraumatology, and he is also a qualified Neuroendoscopic Surgeon. His credentials reflect a consistent track record of advanced surgical training and expertise across a spectrum of subspecialties, reinforcing his status as a versatile and trusted neurosurgeon in both military and civilian healthcare settings.

🌐 Impact and Influence

Beyond operating rooms and laboratories, Dr. Yoshiura has made meaningful contributions to the broader medical and scientific community through active engagement with multiple professional organizations. He is a core member of the Under 40 Committee of the Japanese Congress for Brain Tumor Surgery, signifying his leadership among emerging neurosurgeons. His involvement spans a wide array of societies, including the Japan Neurosurgical Society, Japanese Society on Surgery for Cerebral Stroke, and Japan Society for Neuro-Oncology, among others. This multi-society participation not only amplifies his influence but also allows him to remain at the cutting edge of developments in neurosurgical practice and policy.

🌍 Service Beyond Borders

Dr. Yoshiura’s compassion and sense of duty extend beyond his professional obligations. In 2010, he volunteered at a kindergarten in Bari, Indonesia, demonstrating his humanitarian spirit and willingness to serve communities in need. This formative experience abroad may have enriched his global outlook on medicine and underscored the human side of healthcare—a trait that continues to inform his interactions with patients and peers alike.

🚀 Legacy and Future Contributions

As a rising leader in neurosurgery within the military-medical sphere, Dr. Yoshiura’s legacy is already being defined by a synthesis of cutting-edge research, exceptional surgical practice, and dedicated mentorship. With his ongoing doctoral work poised to make significant contributions to the treatment of ischemic brain injuries, and his involvement in advanced neurosurgical education, he is set to influence both clinical practices and the next generation of neurosurgeons. His unique integration of military precision and academic rigor ensures that his future contributions will be both impactful and enduring.

Publication

  1. Title: Carotid Endarterectomy with Twisted Internal Jugular Vein Located Anterior to the Common Carotid Artery
    Authors: Arumu Endo, Terushige Toyooka, Kazuya Fujii, Satoru Takeuchi, Toru Yoshiura, Masaya Nakagawa, Yohei Otsuka, Arata Tomiyama, Kojiro Wada
    Year: 2025

 

  1. Title: Effectiveness of Keyhole Clipping of Unruptured Intracranial Aneurysms Detected by “Brain Dock” in Healthy Japanese Adults
    Authors: Toru Yoshiura, Satoru Takeuchi, Terushige Toyooka, Arata Tomiyama, Kojiro Wada, Yasuaki Nakao, Takuji Yamamoto, Kentaro Mori, toruyukiko
    Year: 2023

 

  1. Title: KLC1-ROS1 Fusion Exerts Oncogenic Properties of Glioma Cells via Specific Activation of JAK-STAT Pathway
    Authors: Takashi Fujii, Yoshiko Nakano, Daichi Hagita, Nobuyuki Onishi, Arumu Endo, Masaya Nakagawa, Toru Yoshiura, Yohei Otsuka, Satoru Takeuchi, Mario Suzuki et al.
    Year: 2023

 

  1. Title: Surgical Rescue Technique for Incomplete Burr Hole Using a Small Bone Piece and the Craniotome
    Authors: Toru Yoshiura, Kojiro Wada, Kosuke Kumagai, Satoru Takeuchi, Terushige Toyooka, Otani, Kentaro Mori
    Year: 2019

🔚 Conclusion

Dr. Yoshiura’s journey exemplifies a rare integration of surgical mastery, military discipline, and scientific innovation. His commitment to advancing the field of neurosurgery—through both cutting-edge research and hands-on mentorship—positions him as a future leader in academic and military medicine alike. With a career rooted in service, science, and skill, Dr. Yoshiura is not only shaping current practices but also building a lasting legacy for future generations of neurosurgeons in Japan and beyond.

stefano | Clinical Neuroscience | Innovative Research Award

Published on by Neuroscientists

Dr. Stefano | Clinical Neuroscience | Innovative Research Award

Dr. Stefano, Ospedale Santa Chiara Trento, Italy.

Dr. Stefano Branzoli is a highly accomplished cardiac surgeon with decades of experience spanning Italy, Belgium, and the United States. After completing his medical studies at the University of Pavia, he advanced through elite international training, including a fellowship at the Mayo Clinic. His career has focused on surgical innovation in cardiac electrophysiology, with particular emphasis on thoracoscopic ablation for atrial fibrillation, stroke prevention, and ventricular arrhythmias. Through his roles at Santa Chiara Hospital and Universitair Ziekenhuis Brussel, he has contributed extensively to both clinical practice and academic research.

Profile

Orcid

🧬 Early Academic Pursuits


Dr. Stefano Branzoli began his journey into medicine at the prestigious University of Pavia, where he earned his degree in Medicine and Surgery between 1992 and 1998. Driven by a deep curiosity for cardiovascular science, he embarked on rigorous postgraduate training, marking the start of an extraordinary career in cardiac surgery. His academic excellence soon opened international doors, including a coveted fellowship at the Mayo Clinic in Rochester, Minnesota.

🏥 Professional Endeavors


From 1999 to 2004, Dr. Branzoli honed his clinical expertise as a resident in cardiac surgery at the University of Pavia. He became board-certified after completing the USMLE in 2000, equipping him with transatlantic qualifications. Since 2005, he has served in the Cardiac Surgery Unit at Santa Chiara Hospital in Trento, Italy, while also expanding his reach as a specialist at the Universitair Ziekenhuis Brussel in Belgium since 2019. These dual roles reflect his commitment to advancing surgical standards across borders.Contributions to Cardiac ElectrophysiologyThroughout his career, Dr. Branzoli has been instrumental in the development and refinement of procedures targeting arrhythmias. His clinical and research contributions in thoracoscopic ablation for atrial fibrillation, stroke prevention, and epicardial ablation for ventricular arrhythmias have positioned him as a leading voice in electrophysiological cardiac surgery. He has been particularly focused on minimally invasive techniques that reduce patient recovery time while enhancing procedural efficacy.

🔬 Research Focus and Innovation


Dr. Branzoli’s research portfolio reflects his dedication to solving complex cardiovascular challenges. He has led and contributed to significant projects centered on atrial fibrillation, stroke prevention strategies, and novel ablative techniques. His work bridges the gap between traditional surgical approaches and cutting-edge electrophysiological interventions, helping shape the future of cardiac care through both clinical practice and investigative science.

🏅 Accolades and Recognition


Though modest in demeanor, Dr. Branzoli’s accomplishments have earned him respect in academic and clinical circles alike. His training at the Mayo Clinic—a global epicenter for cardiac research—along with his dual appointments in Italy and Belgium, speak volumes of his international reputation. His involvement in advanced cardiac rhythm management has earned recognition from peers and institutions aiming to elevate surgical excellence.

🌍 Impact and Influence


Beyond the operating theater, Dr. Branzoli’s influence is reflected in the widespread adoption of thoracoscopic ablation techniques and his mentorship of upcoming cardiac surgeons in Europe. By integrating cross-border expertise, he has played a vital role in aligning surgical standards and promoting collaborative research between institutions in Italy, Belgium, and beyond.

🔮 Legacy and Future Contributions


As medicine evolves toward personalized, minimally invasive therapies, Dr. Branzoli stands at the forefront of surgical innovation. His work continues to inspire new pathways in arrhythmia management and stroke prevention. With a career spanning continents and a mind open to continual learning, his legacy is defined not only by lives saved but also by knowledge passed on to future generations of cardiovascular specialists.

Publication

  • Title: Patients with Gastrointestinal Bleeding and Atrial Fibrillation: Potential Ideal Target for Epicardial Appendage Occlusion
    Authors: Stefano Branzoli, Massimiliano Marini, Domenico Catanzariti, Cecilia Pravadelli, Luigi Pannone, Giovanni D’Onghia, Mauro Fantinel, Fabrizio Guarracini, Gaia Franceschini, Mirco Zadro et al.
    Year: 2025

 

  • Title: Heart Team for Left Appendage Occlusion without the Use of Antithrombotic Therapy: The Epicardial Perspective
    Authors: Stefano Branzoli, Fabrizio Guarracini, Massimiliano Marini, Giovanni D’Onghia, Domenico Catanzariti, Elettra Merola, Luciano Annicchiarico, Giulia Casagranda, Chiara Stegagno, Mauro Fantinel et al.
    Year: 2022

 

✅ Conclusion


Dr. Branzoli’s enduring commitment to advancing cardiac surgery has had a meaningful impact on patient care, research, and education. With a legacy rooted in innovation, cross-cultural collaboration, and a passion for arrhythmia management, he continues to influence the evolving field of cardiovascular medicine. His work serves as a bridge between traditional surgical methods and modern electrophysiological therapies—ensuring that the future of heart care is not only safer and more effective but also profoundly human-centered.

Hao Lai | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Hao Lai | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Hao Lai, Zhongshan Hospital, Fudan University, China.

Dr. Hao Lai is a distinguished cardiovascular surgeon and researcher, currently serving as Chief Physician at Zhongshan Hospital, Fudan University. With over 20 years of clinical expertise, he specializes in aortic and cardiovascular surgery. His academic achievements include a Ph.D. in Surgery from Fudan University and significant contributions to the study of epigenetic mechanisms in thoracic aortic dissection. As a principal investigator of nationally funded projects and co-author of influential publications, Dr. Lai combines scientific rigor with clinical innovation. He has also played a key role in medical education and device development through industry collaboration.

Profile

Scopus

 

🎓 Early Academic Pursuits

Dr. Hao Lai began his academic journey with a strong foundation in medical sciences, culminating in a Ph.D. in Surgery from the prestigious Fudan University. His early academic pursuits were marked by a deep interest in cardiovascular physiology and surgical intervention, which later matured into a specialized focus on aortic diseases. His time as a doctoral candidate not only equipped him with rigorous scientific training but also ignited his lifelong commitment to solving complex clinical problems through research.

🏥 Professional Endeavors

Currently serving as Chief Physician at Zhongshan Hospital, Fudan University, Dr. Hao Lai has accumulated over two decades of extensive clinical experience in cardiovascular and aortic surgery. His professional trajectory reflects a seamless integration of surgical excellence with academic leadership. At Zhongshan Hospital, a leading institution in China, he has spearheaded several clinical programs aimed at enhancing patient outcomes in cases of thoracic aortic dissection and other high-risk cardiovascular conditions.

🔬 Contributions and Research Focus

Dr. Lai’s research centers around the epigenetic mechanisms underlying thoracic aortic dissection, with a particular focus on histone modification and DNA methylation. He is the Principal Investigator of a major research project funded by the National Natural Science Foundation of China, which explores the role of H3K36me3 histone modification and DNMT3B-mediated gene body methylation in the pathogenesis of aortic dissection. His scientific efforts bridge molecular pathology with clinical implications, offering new perspectives on the diagnosis and treatment of life-threatening vascular disorders.

🏆 Accolades and Recognition

A respected voice in cardiovascular medicine, Dr. Hao Lai has co-authored numerous influential articles in high-impact journals such as Cardiovascular Research and Advanced Science. His h-index of 18, as listed on Scopus, reflects his consistent scholarly output and the wide academic acknowledgment of his work. In addition, his authorship of the textbook Practical Surgery (3rd Edition), published by People’s Medical Publishing House, stands as a testament to his educational contributions to the next generation of Chinese surgeons.

🧪 Impact and Innovation

Dr. Lai’s research has made a tangible impact on the understanding and treatment of aortic diseases. His investigation into the epigenetic regulation of vascular pathology has opened new avenues for targeted therapies. Moreover, his collaboration with MicroPort Endovascular MedTech demonstrates his commitment to translating research findings into real-world applications, particularly in the development and refinement of endovascular surgical devices.

🌍 Influence and Collaboration

Beyond his direct research and surgical contributions, Dr. Lai’s influence extends into collaborative domains, both nationally and internationally. His leadership in high-level research grants, clinical trials, and industrial partnerships positions him as a central figure in the evolving landscape of cardiovascular surgery. His collaborative spirit fosters innovation and promotes cross-disciplinary dialogue, essential in today’s complex medical research environment.

🔮 Legacy and Future Contributions

As Dr. Hao Lai continues his distinguished career, his legacy is being shaped not only by his surgical accomplishments but also by his contributions to medical science. His ongoing projects are likely to further clarify the molecular landscape of aortic diseases and inspire new therapeutic strategies. Looking ahead, Dr. Lai is poised to remain at the forefront of cardiovascular innovation, committed to improving patient care through a synthesis of research, education, and clinical practice.

Publication

 

Title: Prevalence and predictors of left atrial thrombus in patients with rheumatic atrial fibrillation undergoing cardiac surgery: a cross-sectional study
Authors: J. Cui, Y. Zhang, Y. Wang, Q. Ji, C. Wang
Year: 2025


Title: A novel open-vascular single-branched stent graft in total arch repair of type A aortic dissection one-year results of a prospective multicenter randomized controlled study
Authors: J. Gu, W. Zhang, L. Kang, H. Lai, C. Wang
Year: 2025


Title: Fibroblast Activation Protein Acts as a Biomarker for Monitoring ECM Remodeling During Aortic Aneurysm via 68Ga-FAPI-04 PET Imaging
Authors: C. Hu, H. Tan, Y. Zhang, X. Chen, L. Wang
Year: 2025


Title: Mitochondrial NAD+ deficiency in vascular smooth muscle impairs collagen III turnover to trigger thoracic and abdominal aortic aneurysm
Authors: J. Zhang, Y. Tang, S. Zhang, K. Zhu, W. Zhang
Year: 2025


Title: Correcting mitochondrial loss mitigates NOTCH1-related aortopathy in mice
Authors: Y. Tang, J. Zhang, Y. Fang, Y. Xu, W. Zhang
Year: 2025


Title: Exploration of 68Ga-FAPI-04 PET/MR in Chronic Type B Aortic Dissection
Authors: C. Hu, Y. Zhang, S. Qiu, H. Shi, L. Wang
Year: 2025


Title: Effects of postoperative glucocorticoids on mitigation of organ dysfunction in patients with type A aortic dissection: A randomized controlled trial
Authors: M. Luo, J. Luo, X. Xu, G. Tu, Z. Luo
Year: 2024


Title: Therapeutic results of three-dimensional aortic valve anatomic repair for regurgitant bicuspid aortic valve
Authors: J. Li, C. Wang, Z. Zuo, W. Ding, T. Hong
Year: 2024


Title: 68Ga-FAPI-04 Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Ascending Aortic Aneurysm
Authors: C. Hu, H. Tan, Y. Zhang, H. Lai, L. Wang
Year: 2024


Title: Sex-based outcomes after thoracic endovascular aortic repair: A systematic review and meta-analysis
Authors: Y. Zhang, Y. Zhang, Y. Wang, L. Wang, Q. Ji
Year: 2025

✅ Conclusion

Dr. Hao Lai’s career represents a powerful blend of surgical precision, scientific insight, and academic leadership. His work has advanced the understanding of aortic diseases at the molecular level while improving surgical outcomes for patients. As he continues to mentor, innovate, and lead research at the intersection of epigenetics and cardiovascular pathology, Dr. Lai’s contributions are set to leave a lasting legacy in both clinical practice and medical science.

 

 

CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. CARMINA MONTOLIU | Clinical Neuroscience | Best Researcher Award

Prof. Dr.  CARMINA MONTOLIU, UNIVERSIDAD DE VALENCIA/INCLIVA,  Spain.

Carmina Montoliu Felix, a Valencia-born scientist and educator, is a distinguished Catedrática de Universidad at the Universidad de Valencia, specializing in Cellular Biology and Pathology. With a strong foundation in biomedical sciences and a dual role in both academia and clinical research through INCLIVA, she has become a key figure in translational medicine in Spain. Her work focuses on uncovering cellular mechanisms of disease, supported by national recognition such as her Group A classification by ISCIII. With extensive contributions indexed on platforms like ORCID and Scopus, she has gained international visibility and continues to influence the fields of pathology and biomedicine.

Profile

Orcid

 

🎓 Early Academic Pursuits

Carmina Montoliu Felix was born in Valencia, where she also pursued her academic career rooted in the life sciences. Her early interest in biology and medical sciences led her through a rigorous academic pathway that would eventually shape her into a leading figure in cellular pathology. With a profound dedication to understanding human disease at the cellular level, she cultivated a strong foundation in biology, which became the cornerstone of her future specialization in Cellular Biology and Pathology. These formative years instilled in her a passion for translational research, which continues to drive her work.

🏛️ Professional Endeavors

Currently serving as a Catedrática de Universidad at the Facultad de Medicina y Odontología of the Universidad de Valencia, Carmina Montoliu Felix holds a prestigious position within the Departamento de Patología, specifically in the Unidad de Biología. She achieved this distinguished academic rank on November 3, 2023, under BOE nº 274, a recognition of her academic excellence and contributions to higher education. Alongside her academic post, she is also an investigadora adscrita at the Fundación INCLIVA, playing a dual role in both teaching and active biomedical research. Her employment reflects the seamless integration between university instruction and clinical research aimed at improving patient outcomes.

🧬 Contributions and Research Focus

Carmina Montoliu Felix has been a pivotal contributor to the field of Cellular Biology, with specific expertise in Pathology (Área 661). Since February 29, 2012, she has been classified as a Group A Researcher within the Instituto de Salud Carlos III (ISCIII) framework. Her research activities are aligned with the Programa de Estabilización de Investigadores and the Sistema Nacional de Salud (I3SNS), focusing on intensifying biomedical research and fostering translational discoveries. Her scientific work is characterized by its interdisciplinary nature and commitment to uncovering the molecular basis of diseases, contributing significantly to both national and international health research landscapes.

🏅 Accolades and Recognition

Dr. Montoliu Felix’s academic excellence has been affirmed through numerous accolades, including the Group A classification by the Comisión Técnica de Evaluación de Recursos Humanos del ISCIII, one of the highest distinctions for biomedical researchers in Spain. Her appointment as a full professor is a testament to her leadership in medical education and scientific research. She is widely recognized among her peers for her scholarly impact, rigor, and commitment to nurturing future scientists and medical professionals.

🌍 Impact and Influence

Her work not only resonates within academic circles but also extends into clinical research through her active role at INCLIVA. By integrating research and practice, Carmina Montoliu Felix exemplifies how scientific inquiry can lead to tangible health benefits. Her influence spans collaborations with national healthcare systems and academic institutions, reinforcing her role as a key figure in the biomedical field. Through platforms such as ORCID and Scopus (ORCID ID: 0000-0002-4740-4788; Scopus ID: 6701923138), her contributions are accessible globally, further amplifying her scientific impact.

🔬 Legacy and Future Contributions

With a career marked by consistent advancement and dedication to discovery, Carmina Montoliu Felix is poised to continue shaping the future of cellular pathology and biomedical research in Spain and beyond. Her dual engagement in academia and clinical research ensures that her legacy will include both scientific breakthroughs and a generation of inspired students and researchers. Looking ahead, she is expected to further expand the integration of molecular biology into clinical diagnostics, ultimately improving patient care through science.

📚 A Life Committed to Science and Society

Beyond her technical expertise and professional roles, Carmina Montoliu Felix embodies the ideals of a scholar deeply committed to the betterment of society through science. Her residence and professional base in Valencia, her continuous academic contributions, and her service within public institutions paint the portrait of a researcher who bridges the lab and the community. Through her enduring efforts, she not only advances knowledge but also enhances the collective understanding of human health and disease.

Publication

  • Title: Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy
    Authors: Lyudmila Tikhonova; Eugene Maevsky; Carmina Montoliu; Elena Kosenko
    Year: 2025

 

  • Title: Ammoniagenic Action of Valproate without Signs of Hepatic Dysfunction in Rats: Possible Causes and Supporting Evidence
    Authors: Gubidat Alilova; Lyudmila Tikhonova; Carmina Montoliu; Elena Kosenko
    Year: 2024

 

  • Title: Automatic Video-Oculography System for Detection of Minimal Hepatic Encephalopathy Using Machine Learning Tools
    Authors: Alberto Calvo Córdoba; Cecilia Elisabet García Cena; Carmina Montoliu
    Year: 2023

 

  • Title: Neurofilament Light Chain Protein in Plasma and Extracellular Vesicles Is Associated with Minimal Hepatic Encephalopathy and Responses to Rifaximin Treatment in Cirrhotic Patients
    Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Amparo Urios; MP Ballester; Teresa San-Miguel; Javier Megías Vericat; Elena Kosenko; Tosca J; Maria-Pilar Rios et al.
    Year: 2023

 

  • Title: Mild Cognitive Impairment Is Associated with Enhanced Activation of Th17 Lymphocytes in Non-Alcoholic Fatty Liver Disease
    Authors: Alessandra Fiorillo; Juan José Gallego Roig; Franc Casanova; Carla Giménez-Garzó; Amparo Urios; MP Ballester; Lucia Durbán; Maria-Pilar Rios; Javier Megías Vericat; Teresa San-Miguel et al.
    Year: 2023

 

  • Title: Erythrocytes Functionality in SARS-CoV-2 Infection: Potential Link with Alzheimer’s Disease
    Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
    Year: 2023

 

  • Title: Plasma Extracellular Vesicles Play a Role in Immune System Modulation in Minimal Hepatic Encephalopathy
    Authors: Juan José Gallego; Alessandra Fiorillo; Franc Casanova-Ferrer; Amparo Urios; MP Ballester; Lucia Durbán; Javier Megías; Teresa Rubio; Andrea Cabrera-Pastor; Desamparados Escudero-García et al.
    Year: 2022

 

  • Title: Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression
    Authors: Teresa San-Miguel; Javier Megías; Daniel Monleon; Lara Navarro Cerveró; Lisandra Muñoz; Carmina Montoliu; Marina Meri; Pedro Roldán; Miguel Cerdá-Nicolás; Concha López-Ginés
    Year: 2022

 

  • Title: Is NMDA-Receptor-Mediated Oxidative Stress in Mitochondria of Peripheral Tissues the Essential Factor in the Pathogenesis of Hepatic Encephalopathy?
    Authors: Elena Kosenko; Lyudmila Tikhonova; Gubidat Alilova; Carmina Montoliu
    Year: 2022

 

  • Title: A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease
    Authors: Carla Giménez-Garzó; Alessandra Fiorillo; MP Ballester; Juan José Gallego Roig; Franc Casanova-Ferrer; Amparo Urios; Salvador Benlloch; Marti-Aguado D; Teresa San-Miguel; Tosca J et al.
    Year: 2021

 

✅ Conclusion

Carmina Montoliu Felix’s career reflects a rare blend of scientific rigor, academic leadership, and social impact. Her journey from student to full professor showcases her dedication to advancing both knowledge and healthcare. As she continues to lead research at the intersection of cellular biology and clinical application, her legacy will not only be measured in published studies and prestigious titles, but also in the real-world health outcomes and inspired minds her work cultivates. Her future contributions promise to deepen our understanding of disease and strengthen the bridge between science and society.

 

Gilles Rode | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Gilles Rode | Clinical Neuroscience | Best Researcher Award

Dr. Gilles Rode is a distinguished figure in the field of Physical Medicine and Rehabilitation (PMR), holding significant positions at both academic and clinical institutions in France. His career spans decades, with a strong foundation built on his dual M.D. and Ph.D., which paved the way for his pioneering work in neuroplasticity and motor rehabilitation. As the Head of the Department of Rehabilitation at Hôpital Henry Gabrielle and the Dean of the Faculty of Medicine Lyon-Est, he has contributed extensively to the development of rehabilitation practices, medical education, and research. Dr. Rode’s research focuses on understanding neurological recovery and enhancing rehabilitation techniques for patients with brain injuries, while his leadership roles in organizations like the French Society of Physical Medicine and Rehabilitation (Sofmer) and the European Academy of Rehabilitation and Physical Medicine underscore his impact on a global scale.

Profile

Scopus

 

Early Academic Pursuits 📚


Gilles Rode’s academic journey began with a strong foundation in medicine and physical rehabilitation, which led him to pursue a dual M.D. and Ph.D. This unique combination of clinical and scientific expertise laid the groundwork for his exceptional career. His training at esteemed institutions in France, particularly at Université Claude Bernard Lyon 1, has enabled him to delve deeply into the complexities of physical medicine and rehabilitation (PMR). It was during this phase that Dr. Rode developed an interest in combining clinical work with cutting-edge research, exploring the rehabilitation processes from both medical and scientific perspectives.

Professional Endeavors 🏥


In his professional career, Dr. Rode has held pivotal roles in both clinical and academic settings. Since 2009, he has served as the Head of the Department of Rehabilitation at Hôpital Henry Gabrielle, part of the Hospices Civils de Lyon. This role allowed him to shape the development of rehabilitation practices within a leading French hospital. Furthermore, between 2009 and 2016, he contributed significantly as the Vice-Dean at the Faculty of Medicine Lyon-Est, Université Claude Bernard Lyon 1, a position that gave him a platform to influence medical education. His leadership and vision have consistently propelled the field forward, particularly in the integration of advanced rehabilitation techniques into patient care.

Contributions and Research Focus 🔬

Dr. Rode’s research has consistently focused on enhancing physical rehabilitation methods, particularly for individuals recovering from neurological impairments. His scientific inquiries are centered on understanding the mechanisms of neuroplasticity and recovery in brain-injured patients. As a leading member of the Centre de Recherche en Neurosciences de Lyon, his work integrates neuroscience with rehabilitation science, aiming to improve clinical practices and outcomes. His pioneering studies on motor rehabilitation and the use of innovative techniques for brain injury recovery have earned him recognition within both the scientific and medical communities.

Accolades and Recognition 🏅


Dr. Rode’s commitment to advancing the field of physical medicine and rehabilitation has been recognized through numerous accolades. He served as the President of the French Society of Physical Medicine and Rehabilitation (Sofmer) from 2013 to 2016, a position that allowed him to advocate for the integration of contemporary rehabilitation approaches in French healthcare. In 2015, he was elected as a member of the European Academy of Rehabilitation and Physical Medicine, further cementing his status as a leader in the field. His leadership roles and scientific contributions have earned him significant recognition both nationally and internationally.

Impact and Influence 🌍


Dr. Rode’s impact extends far beyond his clinical and academic roles. His work has influenced policies in rehabilitation medicine and has set standards for how rehabilitation should be practiced in hospital settings. As the Dean of the Faculty of Medicine Lyon-Est, he has been at the forefront of shaping medical curricula to ensure that the next generation of doctors is well-equipped to address the challenges of rehabilitation medicine. His ability to bridge the gap between research and clinical practice has resulted in more effective therapies and patient outcomes, impacting countless lives.

Legacy and Future Contributions 🔮


As Dr. Rode continues his work, his legacy is one of both clinical excellence and scientific innovation. His research has had a lasting effect on how physical medicine and rehabilitation are perceived in the medical community. Moving forward, Dr. Rode is expected to continue influencing the development of rehabilitation therapies, particularly in the areas of neuroplasticity and motor recovery. His future contributions will undoubtedly build on the foundation he has established, ensuring that patients continue to benefit from the evolving advancements in rehabilitation medicine.

Global Influence and Leadership 🌐


Dr. Rode’s reputation extends beyond the borders of France, as he is often invited to share his expertise at international conferences and seminars. His leadership in both academia and professional societies has made him a global voice in rehabilitation. Through his active involvement in the European Academy of Rehabilitation and Physical Medicine, he continues to contribute to the global exchange of ideas, driving the evolution of rehabilitation practices across Europe and beyond. Dr. Rode’s influence is not just felt in France but is also shaping the future of rehabilitation medicine worldwide.

Publication

  • Title: Determining the influence of a sleep improvement intervention on medical students’ sleep and fatigue: protocol of the PROMESS-Sleep clinical trial
    Authors: Ruet, Axelle; Ndiki Mayi, Evrard Florentin; Métais, Angèle; Rode, Gilles; Schlatter, Sophie T.
    Year: 2025

 

  • Title: Determining the influence of an intervention of stress management on medical students’ levels of psychophysiological stress: the protocol of the PROMESS-Stress clinical trial
    Authors: Métais, Angèle; Omarjee, Mohammad; Valero, Bérénice; Rode, Gilles; Schlatter, Sophie T.
    Year: 2025

 

  • Title: Co-administration of methylphenidate and prism adaptation would require striatal integrity to alleviate spatial neglect: A preliminary study
    Authors: Beaudoin-Gobert, Maude; Benistant, Faustine; de Lanversin, Maxence; Rossetti, Yves; Luauté, Jacques
    Year: 2024 (presumed, not listed but grouped contextually)

 

  • Title: Updates on post-stroke rehabilitation
    Authors: Charbonnier, Geoffroy; Bihel, Lucie; Jacquin-Courtois, Sophie; Rode, Gilles; Mateo, Sébastien
    Year: 2024 (presumed)

 

  • Title: Effect of coping interventions on performance of medical students during objective structured clinical examination: A randomized controlled trial
    Authors: Schlatter, Sophie T.; Berland, Alexandre; Lutz, Antoine; Rode, Gilles; Lilot, Marc E.
    Year: 2025

 

  • Title: Associations of coping and health-related behaviors with medical students’ well-being and performance during objective structured clinical examination
    Authors: Barret, Noémie; Guillaumée, Théodore; Rimmelé, Thomas R.; Lilot, Marc E.; Schlatter, Sophie T.
    Year: 2024

 

  • Title: Grasping rehabilitation using motor imagery with or without neurofeedback after tetraplegia: A study protocol for a bicentric randomised controlled trial
    Authors: Charbonnier, Geoffroy; Reilly, Karen T.; Schwartz, Denis P.; Rode, Gilles; Mateo, Sébastien
    Year: 2024

 

  • Title: Neck muscle vibration and prism adaptation fail to improve balance disturbances after stroke: A multicentre randomised controlled study
    Authors: Leplaideur, Stephanie; Allart, Etienne; Chochina, Lucie; Bannier, Élise; Bonan, Isabelle Véronique
    Year: 2024

 

  • Title: Striking the Balance: Embracing Technology While Upholding Humanistic Principles in Neurorehabilitation
    Authors: Ardaillon, Hugo; Ribault, Shams; Herault, Caroline; Reilly, Karen T.; Rode, Gilles
    Year: 2024

 

  • Title: Implicit and explicit motor imagery ability after SCI: Moving the elbow makes the difference
    Authors: Mateo, Sébastien; Guillot, Aymeric; Henkous, Sonia; Collet, Christian; Di Rienzo, Franck
    Year: 2024

 

Conclusion


Dr. Gilles Rode’s work has left an indelible mark on the field of rehabilitation, where his contributions have influenced both clinical practices and academic curricula. His dedication to improving patient outcomes through innovative rehabilitation methods, combined with his leadership and advocacy in professional societies, ensures that his influence will continue for years to come. As he progresses in his career, Dr. Rode remains a key figure in advancing the field of physical medicine and rehabilitation, shaping both the future of patient care and the next generation of healthcare professionals. His legacy will continue to inspire progress in rehabilitation science, benefiting countless individuals across the globe.

Handrean Soran | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Handrean Soran | Clinical Neuroscience | Best Researcher Award

Prof. Handrean Soran,  Manchester University NHS Foundation Trust, United Kingdom.

Dr. Handrean Soran is a distinguished British endocrinologist and researcher with expertise in diabetes, endocrinology, and cardiovascular diseases. His academic journey began in Iraq and advanced through the UK, where he earned prestigious medical qualifications, including an MD in Medicine and MSc in Diabetes and Endocrinology. Throughout his career, Dr. Soran has contributed significantly to research on the relationship between diabetes and cardiovascular health, publishing extensively in high-impact journals like The New England Journal of Medicine and Lancet. His work has garnered global recognition, including an H-index of 49 and numerous accolades, solidifying his position as a leader in his field.

Profile

Google Scholar

 

Early Academic Pursuits 📚

Handrean Soran’s academic journey began in the Kurdistan region of Iraq, where he completed his A-levels with an impressive score of 94.5% from Sulemani High School in 1985. His drive for knowledge led him to pursue his MBChB at Al-Mustansyria University in Baghdad, Iraq, graduating in 1990. This foundational education set the stage for a career dedicated to medical research and practice. After completing his medical degree, he pursued further specialized training in the UK, where he earned his MRCP from the Royal College of Physicians in Edinburgh in 1999, and later, an MSc in Diabetes and Endocrinology from the University of Liverpool in 2006. These early academic milestones laid the foundation for his later expertise in endocrinology and diabetes, fields that would define his career.

Professional Endeavors 🏥

Dr. Handrean Soran’s professional journey is marked by a dedication to medicine, particularly in the fields of endocrinology and diabetes. He has held significant roles in prestigious institutions, with his current position in the Department of Diabetes, Endocrinology, and Metabolism at Manchester University Hospitals NHS Foundation Trust. His medical career was further enhanced by his qualifications as a Fellow of the Royal College of Physicians (FRCP) from both Glasgow and Edinburgh. Throughout his career, Dr. Soran has worked on developing innovative approaches in clinical care and research, constantly striving to improve patient outcomes and advancing medical knowledge.

Contributions and Research Focus 🔬

Dr. Soran’s research focus primarily centers on diabetes, endocrinology, and cardiovascular health, specifically the interplay between metabolic disorders and heart disease. His research efforts have been integral to understanding the link between diabetes and cardiovascular risk, with a significant body of work examining the effects of treatments on these interconnected conditions. His contributions have been recognized through multiple high-impact publications in renowned journals such as the New England Journal of Medicine, Lancet, and European Heart Journal. With an H-index of 49 and over 130 citations, Dr. Soran’s work continues to shape the clinical landscape in these areas, driving further advancements in treatment protocols and therapeutic strategies for diabetes and cardiovascular diseases.

Accolades and Recognition 🏆

Dr. Soran’s career has been decorated with numerous accolades, affirming his status as a leader in his field. He achieved the prestigious title of Fellow of the Royal College of Physicians (FRCP) in both Edinburgh and Glasgow, a testament to his clinical expertise and contribution to medical science. His groundbreaking work in diabetes and cardiovascular research has earned him recognition not only from peers but also from major medical institutions. His publications in top-tier journals further highlight his academic prowess, solidifying his position as a key thought leader in the medical and academic communities.

Impact and Influence 🌍

Dr. Handrean Soran’s work extends beyond the realm of research publications; it has made a lasting impact on the clinical management of diabetes and cardiovascular diseases worldwide. His insights have contributed to shaping healthcare policies and clinical practices, particularly in the management of diabetic patients at high cardiovascular risk. Through his collaboration with the Division of Cardiovascular Sciences at the University of Manchester, he has fostered interdisciplinary approaches to solving complex medical challenges, advancing the integration of cardiovascular care with endocrinology. His work has influenced not only academic circles but also clinical practice, providing new directions for patient care.

Legacy and Future Contributions 🌱

As Dr. Soran continues his impactful work, his legacy is one of dedication to improving patient health outcomes and advancing the fields of endocrinology and diabetes. With a deep commitment to teaching and mentorship, Dr. Soran plays a pivotal role in training the next generation of doctors and researchers. His future contributions are poised to further explore the intricate relationship between metabolic disorders and cardiovascular health, addressing the growing global burden of these interconnected diseases. His work will undoubtedly continue to guide both clinical practice and future research in endocrinology, diabetes, and cardiovascular medicine, ensuring his ongoing influence in these critical areas.

Global Recognition and Influence 🌐

Dr. Soran’s influence reaches across borders, as evidenced by his extensive publication record and recognition within the global medical community. His research has not only enriched the scientific literature but also contributed to global health initiatives, particularly in the area of metabolic disorders and cardiovascular diseases. With collaborations spanning multiple continents, Dr. Soran is dedicated to improving health outcomes globally, offering expert insights into the prevention and management of diabetes and heart disease. His role in shaping clinical guidelines and his participation in international research collaborations further amplify his global impact.

Academic and Professional Leadership 🎓

In addition to his research contributions, Dr. Soran’s leadership within academia is profound. He holds multiple academic positions, including his affiliation with the University of Manchester, where he plays an integral role in advancing research within the Division of Cardiovascular Sciences. His leadership extends to mentoring young researchers and clinicians, helping to foster a new generation of experts in endocrinology and diabetes. Dr. Soran’s academic vision continues to drive progress in both education and research, making significant strides in improving how diabetes and cardiovascular diseases are understood and treated. His future work promises to leave a lasting mark on medical education and the advancement of scientific knowledge.

Publication

  • Cardiovascular efficacy and safety of bococizumab in high-risk patients
    Author: PM Ridker
    Year: 2017

 

  • Volanesorsen and triglyceride levels in familial chylomicronemia syndrome
    Author: JL Witztum
    Year: 2019

 

  • Triglyceride lowering with pemafibrate to reduce cardiovascular risk
    Author: A Das Pradhan
    Year: 2022

 

  • Diabetes dyslipidemia
    Author: JD Schofield
    Year: 2016

 

  • Lysosomal acid lipase deficiency–an under-recognized cause of dyslipidaemia and liver dysfunction
    Author: Ž Reiner
    Year: 2014

 

  • Obesity: a critical risk factor in the COVID‐19 pandemic
    Author: S Kwok
    Year: 2020

 

  • Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
    Author: KK Ray
    Year: 2019

 

  • Hypercholesterolaemia and its management
    Author: D Bhatnagar
    Year: 2008

 

  • Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
    Author: B Williams
    Year: 2018

 

  • Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset …
    Author: FJ Raal
    Year: 2017

 

Conclusion

Dr. Handrean Soran’s career is marked by profound contributions to medical science, particularly in the fields of diabetes and cardiovascular health. His groundbreaking research and clinical expertise have had a significant impact on both academic and healthcare practices worldwide. As a recognized leader in his field, Dr. Soran’s work continues to influence the management of metabolic and cardiovascular diseases, and his future contributions promise to further advance these critical areas of medical research and practice. His legacy is one of dedication, leadership, and a commitment to improving health outcomes globally.